期刊文献+

40例硫辛酸治疗糖尿病周围神经病变临床分析

Clinical Analysis of 40 Cases of Treating Diabetic Peripheral Neuropathy with Lipoic Acid
在线阅读 下载PDF
导出
摘要 目的:研究硫辛酸治疗糖尿病周围神经病变临床效果及安全性。方法:将40例糖尿病周围神经病变病人,随机分为对照组和治疗组,治疗组在常规治疗基础上采用硫辛酸进行治疗,对照组患者在常规治疗基础上给予维生素B1、B12治疗,随访3个月。采用多伦多临床评分系统比较患者治疗前后症状分、反射分、感觉分及总分;观察2组的临床总评分的改善状况。结果:两组患者治疗前后症状分、反射分、感觉分、总分比较差异均有统计学意义(P<0.05);治疗后组间各积分比较,差异均有统计学意义(P<0.05,P<0.01)。结论:运用硫辛酸治疗糖尿病周围神经病变疗效肯定、安全性高。 Objective: To study the efficacy and safety of lipoic acid in the treatment of diabetic peripheral neuropathy. Methods: 40 cases of patients with diabetic peripheral neuropathy were randomly divided into control group and treatment group,treatment group was given lipoic acid treatment in addition to conventional treatment,and control group was given vitamin B1,B12 treatment in addition to conventional treatment. The patients were followed up for 3 months. The Toronto Clinical Scoring Systems was used to compare the symptom score,reflection score,feeling score and total score of the two groups before and after the treatment. Observe the improvement of the clinical total scores of the two groups. Results: The differences between the symptom score,reflection score,feeling score and total score of the two groups before and after the treatment were statistically significant( P < 0. 05); The differences of the scores after the treatment were statistically significant( P < 0. 05,P < 0. 01). Conclusion: Using lipoic acid to treat diabetic peripheral neuropathy has remarkable effect and high safety.
作者 曾秀梅
出处 《数理医药学杂志》 2016年第3期348-349,共2页 Journal of Mathematical Medicine
关键词 2型糖尿病 糖尿病周围神经病变 硫辛酸 Type 2 diabetes diabetic peripheral neuropathy lipoic acid
  • 相关文献

参考文献5

二级参考文献27

  • 1田睿,赵志刚.糖尿病神经病变的筛查和诊断[J].中国医学前沿杂志(电子版),2012,4(3):39-42. 被引量:6
  • 2Perkins B A, Bril V, Olaleye D, et al. Simple screening tests for peripheral neuropathy in the diabetes clinic [ J ]. Diabetes Care, 2001, 24(2):250-256.
  • 3Bril V, Perkins B A. Validation of the Toronto clinical scotinS system for diabetic polyneuropathy [ J ]. Diabetes Care, 2002, 25(11) :2048-2052.
  • 4Fabian W, Majkowska L, Stefanski A, et al. Prevalence of diabetes, antidiabetic treatment and chronic diabetic complications reported by the general practitioners [ J ]. Przegl Lek, 2005,62(4) :201-205.
  • 5Janghorbani M, Rezvanian H, Kachooei A, et al. Peripheral neuropathy in Type 2 diabetes mellitus in Isfahan, Iran: prevalence and risk facwrs [ J ]. Acta Neurel Scand, 2006,114(6) :384-391.
  • 6Bouhon A J, Vinik A I, Arezzo J C, et al. A statement by the Amecican diabetes association: Diabetic neuropathies [J]. Diabetes Care, 2005, 28(4) :956-962.
  • 7Dyck P J, Davies J L, Wilson D M, et al. Risk factors for severity of diabetic polyneuropathy : intensive longitudinal assessment of the Rochester Diabetic Neuropathy Study cohort [J]. Diabetes Care, 1999,22(9) :1479-1486.
  • 8Brownlec M. The pathobiology of diabetic complications. A unifying mechanism [ J ]. Diabetes, 2005, 54 ( 6 ) : 1615-1625.
  • 9Davies M, Brophy S, Williams R, et al. The prevalence, severity, and impact of painful diabetic peripheral neuropathy in Type 2 diabetes [ J ] . Diabetes Care, 2006, 29 ( 7 ) : 1518-1522.
  • 10孙蕊,刘世超.α-硫辛酸联合甲钴胺治疗糖尿病周围神经病变37例[J].中国医药写报,2010,7(33):156.

共引文献182

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部